Virtus ETF Advisers’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-20,379
| Closed | -$99K | – | 407 |
|
|
2021
Q3 | $99K | Sell |
20,379
-1,068
| -5% | -$5.19K | 0.04% | 383 |
|
|
2021
Q2 | $146K | Buy |
+21,447
| New | +$146K | 0.06% | 394 |
|
|
2018
Q4 | – | Sell |
-42,584
| Closed | -$413K | – | 396 |
|
|
2018
Q3 | $413K | Sell |
42,584
-31,186
| -42% | -$302K | 0.04% | 153 |
|
|
2018
Q2 | $752K | Buy |
73,770
+31,037
| +73% | +$316K | 0.66% | 69 |
|
|
2018
Q1 | $556K | Buy |
42,733
+23,153
| +118% | +$301K | 0.48% | 109 |
|
|
2017
Q4 | $350K | Buy |
19,580
+4,854
| +33% | +$86.8K | 0.44% | 87 |
|
|
2017
Q3 | $370K | Buy |
14,726
+1,347
| +10% | +$33.8K | 0.05% | 116 |
|
|
2017
Q2 | $322K | Sell |
13,379
-6,830
| -34% | -$164K | 0.05% | 104 |
|
|
2017
Q1 | $389K | Buy |
20,209
+1,938
| +11% | +$37.3K | 0.07% | 117 |
|
|
2016
Q4 | $281K | Buy |
+18,271
| New | +$281K | 0.08% | 114 |
|
|
2016
Q2 | – | Sell |
-14,884
| Closed | -$226K | – | 153 |
|
|
2016
Q1 | $226K | Sell |
14,884
-935
| -6% | -$14.2K | 0.31% | 70 |
|
|
2015
Q4 | $300K | Buy |
+15,819
| New | +$300K | 0.82% | 31 |
|